Free Trial
→ Tim Sykes’ Urgent Trade Alert: “Make this move now” (From Timothy Sykes) (Ad) Free FDMT Stock Alerts

4D Molecular Therapeutics (FDMT) Insider Trading & Ownership

$8.45
-0.21 (-2.42%)
(As of 10/17/2024 ET)
Compare

4D Molecular Therapeutics (NASDAQ:FDMT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$16.38 M
Get FDMT Insider Trade Alerts

Want to know when executives and insiders are buying or selling 4D Molecular Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

FDMT Insider Buying and Selling by Quarter

Ad Darwin
Unlock the Secret to Earning Consistent Income from Stocks Under $30!
Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!
👉 Yes, I Want the Free Report! 👈

4D Molecular Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/16/2024Scott BizilyInsiderSell500$16.33$8,165.00  
7/16/2024Scott BizilyInsiderSell1,750$27.11$47,442.50  
7/11/2024Scott BizilyInsiderSell1,996$25.00$49,900.00  
7/10/2024David KirnCEOSell12,923$22.49$290,638.27  
7/1/2024Scott BizilyInsiderSell4,248$21.36$90,737.28  
6/24/2024David KirnCEOSell12,930$23.10$298,683.00  
5/16/2024Scott BizilyInsiderSell1,750$25.45$44,537.50  
4/16/2024Scott BizilyInsiderSell1,750$25.74$45,045.00  
4/1/2024Scott BizilyInsiderSell8,153$31.78$259,102.34  
3/27/2024Scott BizilyInsiderSell5,833$35.04$204,388.32  
3/18/2024Scott BizilyInsiderSell1,750$31.27$54,722.50  
2/27/2024Scott BizilyInsiderSell1,909$30.00$57,270.00  
2/16/2024Scott BizilyInsiderSell1,750$27.67$48,422.50  
2/8/2024David KirnCEOSell92,001$27.13$2,495,987.13  
2/8/2024Scott BizilyInsiderSell6,244$27.50$171,710.00  
2/5/2024Robert Young KimInsiderSell24,552$30.05$737,787.60  
1/23/2024David KirnCEOSell5,696$18.41$104,863.36  
1/4/2024David KirnCEOSell40,732$20.31$827,266.92  
1/4/2024Global Investors Lp VikingMajor ShareholderSell540,000$19.53$10,546,200.00  
(Data available from 1/1/2013 forward)

FDMT Insider Trading Activity - Frequently Asked Questions

The list of insiders at 4D Molecular Therapeutics includes David Kirn, David Schaffer, Global Investors Lp Viking, Jacob Chacko, Robert Young Kim, and Scott Bizily. Learn more on insiders at FDMT.

7.30% of 4D Molecular Therapeutics stock is owned by insiders. Learn more on FDMT's insider holdings.

The following insider purchased FDMT shares in the last 24 months: Global Investors Lp Viking ($13,600,000.00).

Insiders have purchased a total of 850,000 FDMT shares in the last 24 months for a total of $13,600,000.00 bought.

The following insiders have sold FDMT shares in the last 24 months: David Kirn ($5,389,852.24), Global Investors Lp Viking ($10,546,200.00), Jacob Chacko ($100,250.00), Robert Young Kim ($737,787.60), and Scott Bizily ($1,455,899.41).

Insiders have sold a total of 851,291 4D Molecular Therapeutics shares in the last 24 months for a total of $18,229,989.25 sold.

4D Molecular Therapeutics Key Executives

  • Dr. John F. Milligan Ph.D. (Age 63)
    Executive Chairman
    Compensation: $150k
  • Dr. David H. Kirn M.D. (Age 61)
    Co-Founder, CEO & Director
    Compensation: $1.01M
  • Dr. Fariborz Kamal Ph.D. (Age 61)
    President & COO
    Compensation: $786.2k
  • Dr. Noriyuki Kasahara M.D. (Age 61)
    Ph.D., Chief Scientific Officer
    Compensation: $201.29k
  • Dr. Robert Y. Kim M.B.A. (Age 63)
    M.D., Chief Medical Officer
    Compensation: $704.84k
  • Ms. Theresa Janke (Age 49)
    Co-Founder & Chief of Staff
    Compensation: $652.32k
  • Mr. Uneek Mehra (Age 52)
    Chief Financial & Business Officer
  • Dr. Scott P. Bizily J.D. (Age 51)
    Ph.D., Chief Legal Officer & Corporate Secretary
  • Dr. An Song Ph.D.
    Chief Development Officer
  • Dr. Alan H. Cohen FAAAAI (Age 63)
    FAAP, FACAAI, FCCP, M.D., Senior VP & Therapeutic Area Head of Pulmonology

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:

This page (NASDAQ:FDMT) was last updated on 10/17/2024 by MarketBeat.com Staff
From Our Partners
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Retire off just one stock ticker?
ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...
Behind the Markets | Sponsored
Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...
Weiss Ratings | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
We recommended Nvidia in 2016, now we’re recommending this…
The AI boom is just getting started. And the real wealth has still to be made…
Porter & Company | Sponsored
Add $2T of Potential Magic to Your Portfolio
Revolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...
Elf Labs | Sponsored
Market "Famine" Coming
Market Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...
Opportunistic Trader | Sponsored
Massive trading opportunity begins by October 21
October 21 could spark a mania among “next-generation” AI stocks. That’s the newest prediction from a Wall Str...
Brownstone Research | Sponsored